These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

617 related articles for article (PubMed ID: 24572583)

  • 41. Schizophrenia patients with polydipsia and water intoxication are characterized by greater severity of psychotic illness and a more frequent history of alcohol abuse.
    Poirier S; Legris G; Tremblay P; Michea R; Viau-Guay L; Mérette C; Bouchard RH; Maziade M; Roy MA
    Schizophr Res; 2010 May; 118(1-3):285-91. PubMed ID: 20096540
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Treatment of schizoaffective disorder and schizophrenia with mood symptoms.
    Levinson DF; Umapathy C; Musthaq M
    Am J Psychiatry; 1999 Aug; 156(8):1138-48. PubMed ID: 10450252
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Early course of schizophrenia in a representative Dutch incidence cohort.
    Selten JP; Veen ND; Hoek HW; Laan W; Schols D; van der Tweel I; Feller W; Kahn RS
    Schizophr Res; 2007 Dec; 97(1-3):79-87. PubMed ID: 17683911
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Symptomatic and functional recovery from a first episode of schizophrenia or schizoaffective disorder.
    Robinson DG; Woerner MG; McMeniman M; Mendelowitz A; Bilder RM
    Am J Psychiatry; 2004 Mar; 161(3):473-9. PubMed ID: 14992973
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Remission in prognosis of functional outcome: a new dimension in the treatment of patients with psychotic disorders.
    Helldin L; Kane JM; Karilampi U; Norlander T; Archer T
    Schizophr Res; 2007 Jul; 93(1-3):160-8. PubMed ID: 17395430
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Correlates of subjective and functional outcomes in outpatient clinic attendees with schizophrenia and schizoaffective disorder.
    Hofer A; Rettenbacher MA; Widschwendter CG; Kemmler G; Hummer M; Fleischhacker WW
    Eur Arch Psychiatry Clin Neurosci; 2006 Jun; 256(4):246-55. PubMed ID: 16311896
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Long-term course of schizophrenic illness: Bleuler's study reconsidered.
    Modestin J; Huber A; Satirli E; Malti T; Hell D
    Am J Psychiatry; 2003 Dec; 160(12):2202-8. PubMed ID: 14638591
    [TBL] [Abstract][Full Text] [Related]  

  • 48. An 8-year follow-up of patients with DSM-III-R psychotic depression, schizoaffective disorder, and schizophrenia.
    Tsuang D; Coryell W
    Am J Psychiatry; 1993 Aug; 150(8):1182-8. PubMed ID: 8328561
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Psychopathological and social status of patients with affective, schizophrenic and schizoaffective disorders after long-term course.
    Marneros A; Deister A; Rohde A
    Acta Psychiatr Scand; 1990 Nov; 82(5):352-8. PubMed ID: 2281805
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Remission criteria for schizophrenia: evaluation in a large naturalistic cohort.
    De Hert M; van Winkel R; Wampers M; Kane J; van Os J; Peuskens J
    Schizophr Res; 2007 May; 92(1-3):68-73. PubMed ID: 17336500
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Predicting the "revolving door" phenomenon among patients with schizophrenic, schizoaffective, and affective disorders.
    Haywood TW; Kravitz HM; Grossman LS; Cavanaugh JL; Davis JM; Lewis DA
    Am J Psychiatry; 1995 Jun; 152(6):856-61. PubMed ID: 7755114
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Multidimensionally impaired: the good news.
    Stayer C; Sporn A; Gogtay N; Tossell JW; Lenane M; Gochman P; Greenstein D; Sharp W; Rapoport JL
    J Child Adolesc Psychopharmacol; 2005 Jun; 15(3):510-9. PubMed ID: 16092914
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Course of adolescent psychotic disorder with schizoaffective episodes.
    Lay B; Schmidt MH; Blanz B
    Eur Child Adolesc Psychiatry; 1997 Mar; 6(1):32-41. PubMed ID: 9112045
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Gender differences in affective, schizoaffective, and schizophrenic disorders.
    McGlashan TH; Bardenstein KK
    Schizophr Bull; 1990; 16(2):319-29. PubMed ID: 2374887
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Validity of the Spanish version of the Personal and Social Performance scale in schizophrenia.
    Apiquian R; Elena Ulloa R; Herrera-Estrella M; Moreno-Gómez A; Erosa S; Contreras V; Nicolini H
    Schizophr Res; 2009 Jul; 112(1-3):181-6. PubMed ID: 19398302
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The longitudinal course of schizoaffective disorders. A prospective follow-up study.
    Grossman LS; Harrow M; Fudala JL; Meltzer HY
    J Nerv Ment Dis; 1984 Mar; 172(3):140-9. PubMed ID: 6699629
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Duration of untreated psychosis (DUP) and the course of schizophrenia in a 20-year follow-up study.
    Cechnicki A; Cichocki Ł; Kalisz A; Błądziński P; Adamczyk P; Franczyk-Glita J
    Psychiatry Res; 2014 Nov; 219(3):420-5. PubMed ID: 24999174
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Three-year trials of personal therapy among schizophrenic patients living with or independent of family, II: Effects on adjustment of patients.
    Hogarty GE; Greenwald D; Ulrich RF; Kornblith SJ; DiBarry AL; Cooley S; Carter M; Flesher S
    Am J Psychiatry; 1997 Nov; 154(11):1514-24. PubMed ID: 9356558
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Diagnostic stability and long-term symptomatic and functional outcomes in first-episode antipsychotic-naïve patients with schizophrenia.
    Klærke LR; Baandrup L; Fagerlund B; Ebdrup BH; Pantelis C; Glenthøj BY; Nielsen MØ
    Eur Psychiatry; 2019 Oct; 62():130-137. PubMed ID: 31614250
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Symptomatic remission and its relationship to social functioning in Tunisian out-patients with schizophrenia].
    El Gharbi I; Chhoumi M; Mechri A
    Encephale; 2019 Feb; 45(1):15-21. PubMed ID: 29195805
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 31.